関連する実験動画
Updated: Jun 5, 2026

09:21
Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
STRATの臨床リスクスコアは,TAVI後の早期の脳卒中を予測する:FRANCE-TAVIのレジストリ
Matthieu Besutti1, Romain Chopard2, Fiona Ecarnot1
1Department of Cardiology, University Hospital Besançon, Besançon, France; SINERGIES, Université Marie & Louis Pasteur, 25000 Besançon, France.
Archives of cardiovascular diseases
|February 16, 2026
まとめ
新しいSTRATスコアは,トランスキャテーター大動脈弁インプラント (TAVI) の後の不全性脳卒中リスクを予測するのに役立ちます. この実用的なツールは,患者を低リスク,中リスク,高リスクのグループに分類し,個別化された予防を行います.
科学分野:
- 心臓病学 心臓病学
- 神経学 神経学とは
- 医療情報工学 医療情報工学
背景:
- トランスキャテーテル大動脈弁の埋め込み (TAVI) はますます使用されていますが,周回手術による缺血性脳卒中リスクを予測することは依然として困難です.
- 信頼性の高いリスク分層化ツールの欠如は,最適な患者管理と予防戦略の選択を妨げています.
研究 の 目的:
- 臨床リスクスコアを開発し,TAVI後の30日間の脳卒中リスクを正確に分層化するために内部で検証する.
- TAVI後の不全性脳卒中に関連した重要な臨床予測要因を特定する.
主な方法:
- FRANCE-TAVIレジストリからTAVIを受けた62,747人の患者からなる全国的なマルチセンターコホートが分析されました.
- 多変数ロジスティック回帰を用いて予測リスクスコアが作成され,その後にクロス検証技術を用いた内部検証が行われました.
主要な成果:
- 女性の性別,年齢>85歳,低体重,症状状態,前脳卒中/TIA,心不全エピソード,運動能力の低下,糖尿病,低クレアチニンクリアランスを含む9つの臨床予測要因が特定されました.
- STRATスコアは,高い精度 (ブライヤースコア0.18) と優れた校正性を示し,患者を低 (脳卒中リスク2.25%),中等 (6.51%) および高リスク (10.10%) グループに分類しました.
結論:
- 開発されたSTRATスコアは,TAVI患者における早期の缺血性脳卒中を予測するための実用的で効果的な臨床ツールです.
- このスコアはFRANCE-TAVIのレジストリで検証され,予防戦略の調整に役立ちます.
- 外部検証と臨床効果の評価は,さらなる実施のために保証されています.
さらに関連する動画
関連する概念動画
Clinical Trials: Overview
5.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
Ischemic Heart Disease: Overview
3.5K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
3.5K
Relative Risk
2.2K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.2K
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
543
Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...
543
Acute Coronary Syndrome III: Diagnostic Studies
298
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
298
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
357
The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
357

